Quantum BioPharma Provides Corporate Update
Quantum BioPharma retained FinnCom, Inc. for a six-month contract to provide marketing and investor awareness services starting June 24, 2026. The total cash consideration for the agreement is USD 170,500, consisting of a USD 20,500 initiation payment and six monthly installments of USD 25,000.
Key figures
- Contract value usd
- 170500
- Initial payment usd
- 20500
- Monthly payment usd
- 25000
- Ownership uwi percent
- 19.84
- Royalty threshold usd
- 250000000
- Contract duration months
- 6
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.